Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-10T17:17:59.122Z Has data issue: false hasContentIssue false
  • English
  • Français

Poly unsaturated fatty acids: the missing link between cardiac events and depression?

Published online by Cambridge University Press:  04 January 2019

A. Schins ,
A. Honig  and
M. Maes
A. Schins
Affiliation:
Department of Psychiatry, Academic Hospital Maastricht, The Netherlands
A. Honig*
Affiliation:
Department of Psychiatry & Neuropsychology, University of Maastricht, Academic Hospital Maastricht, The Netherlands
M. Maes
Affiliation:
University of Maastricht, Academic Hospital Maastricht, The Netherlands
*
Department of Psychiatry Academic Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands, Tel: 00 31 43 387 7537, Fax: 00 31 43 387 5444 E-mail: Adriaan.Honig@spsy.azm.nl
Get access Rights & Permissions [Opens in a new window]

Summary

The relationship between myocardial infarction (MI), depression and cardiac death is not well understood. There is evidence that poly unsaturated fatty acid (PUFA) metabolism and composition in phospholipids and cholesterylesters are involved in the pathophysiology of affective disorders and cardiac dysregulation. In this paper the relationship of PUFAs with 1) cardiac events 2) depressive disorder and 3) the inflammatory response system (IRS) will be reviewed. The underlying pathophysiologic mechanisms relate to the effects of dietary fatty acids on the IRS, the HPA-axis, serotonin metabolism and platelet reactivity. These effects are the result of the important effects of PUFAs on the structure and function of localized membrane domains, their involvement in eicosanoid synthesis and their influence on intra-cellular signalling pathways and gene expression. Antidepressive treatment has been shown to have immunosuppressive effects in healthy volunteers. In patients with bipolar disorder or schizophrenia, PUFA supplementation resulted in significant symptom reduction. In the ongoing substudy of the MIND-IT, the effects of antidepressive treatment on immune status, PUFA composition in serum phospholipids and cholesterylesters and whole blood serotonin in depressive post-MI patients will be investigated. More knowledge on the relationships between PUFAs in diet, IRS parameters and serotonin metabolism may alter treatment strategies in the prevention of both cardiac death and the occurrence of depressive disorder in cardiac patients.

Keywords

PUFAdepressionmyocardial infarctioncytokinesserotoninplatelet reactivity
Type
Articles
Information
Acta Neuropsychiatrica , Volume 13 , Issue 2 , June 2001 , pp. 38 - 45
Copyright
Copyright © Cambridge University Press 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Frasure-Smith, N, Lesperance, F, Talajic, M. Depression following myocardial infarction: impact on 6-months survival. JAMA 1993;270:999–1005.Google Scholar
2. Frasure-Smith, N, Lesperance, F, Talajic, M. Depression and 18 months prognosis after myocardial infarction. Circulation 1995;91:999–1005.Google Scholar
3. Ladwig, KH, Roll, G, Breithardt, G, Budde, T, Borggrefe, M. Post infarct depression and incomplete recovery 6 months after acute myocardial infarction. The Lancet 1994;343:20–23.Google Scholar
4. Heuser, I. The hypothalamic-pituitary-adrenal system in depression. Pharmacopsychiatry 1998;31:10–13.Google Scholar
5. Anda, R, Williamson, D, Jones, D, et al. Depressed affect, hopelessness, and the risk of ischcmic heart disease in a cohort of U.S. adults [see comments). Epidemiol 1993;4:285–294.Google Scholar
6. Wulsin, LR, Vaillant, GE, Wells, VE. A systematic review of the mortality of depression. Psychosom Med 1999;61:6–17.Google Scholar
7. Whooley, MA, Browner, WS. Association between depressive symptoms and mortality in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1998;159:2129–2135.Google Scholar
8. Ferketich, AK, Schwartzbaum, JA, Frid, DJ, Moeschberger, ML. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med 2000;160:1261–1268.Google Scholar
9. Ariyo, AA, Haan, M, Tangen, CM, et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly americans [In Process Citation]. Circulation 2000;102:1773–1779.Google Scholar
10. Honig, A, Lousberg, R, Wojchiechowski, F, Cheriex, EC, Wellens, H, Van Praag, HM. Depressie na een eerste hartinfarct: overeenkomsten en verschillen met een gewone depressie. Depression following a first myocardial infarction; similarities with and difference from ‘ordinary’ depression. Ned Tijdschr Geneeskunde 1997;141:196–199.Google Scholar
11. Maes, M, Smith, R, Christophe, A, Cosyns, P, Desnyder, R, Meltzer, H. Fatty acid composition in major depression: decreased n3 fractions in cholesteryl esters and increased C20:4n6/C20 : 5n3 ratio in cholesteryl esters and phospholipids. J Affect Disord 1996;38:35–46.Google Scholar
12. Maes, M, Christophe, A, Delanghe, J, Altamura, C, Neels, H, Meltzer, H. Lowered n3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatr Res 1999;85:275–291.Google Scholar
13. Peet, M, Murphy, B, Shay, J, Horrobin, D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998;43:315–319.Google Scholar
14. Albert, CM, Hennekens, CH, O'Donnel, CJ, et al. Fish consumption and risk of cardiac death. JAMA 1998;279:23–28.Google Scholar
15. Siscovick, DS, Raghunathan, TE, King, I, et al. Dietary intake and cell membrane levels of long chain n-3 polyunsaturated fatty acid and the risk of primary cardiac arrest. JAMA 1995;274:1363–1367.Google Scholar
16. Burr, ML, Fehily, AM, Gilbert, JF, et al. Effects of changes in fat, fish and fibre intakes on death in myocardial reinfarction: diet and reinfarction trial. Lancet 1989;2:757–761.Google Scholar
17. Calder, PC. Dietary fatty acids and the immune system. Lipids 1999;34:S137–140.Google Scholar
18. Spector, AA. Essentiality of fatty acids. Lipids 1999;34:Sl–3.Google Scholar
19. Bourre, JM, Dunionl, O, Durand, G. Brain phospholipids as dietary source of (n-3) polyunsaturated fatty acids for nervous tissue in the rat. J Neurochem 1993;60:2018–2028.Google Scholar
20. Bourre, JM, Bonneil, M, Clement, M, et al. Function of dietary polyunsaturated fatty acids in the nervous system. Prostaglandins Leukotr Essent Fatty Acids 1993;48:5–15.Google Scholar
21. Yehuda, S, Rabinovitz, S, Mostofsky, DI. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J Ncurosci Res 1999;56:565–570.Google Scholar
22. Fernstrom, JD. Can nutrient supplements modify brain function? Am J Clin Nutr 2000:71:1669S–1675S.Google Scholar
23. Aromaa, A, Raitasalo, R, Reunanen, A, et al. Depression and cardiovascular diseases. Acta Scand Psychiatr 1994;(Suppl.)377:77–82.Google Scholar
24. Pratt, LA, Ford, DE, Crum, RM, Armenian, HK, Gallo, JJ, Eaton, WW. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation 1996;94:3123–3129.Google Scholar
25. Barefoot, JC, Schroll, M. Symtomps of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93:1976–1980.Google Scholar
26. Ford, DE, Mead, LA, Chang, PP, Cooper-Patrick, L, Wang, N-Y, Klag, MJ. Depression is a risk factor for coronary artery disease in men. Arch Int Med 1998;158:1422–1426.Google Scholar
27. Lesperance, F, Frasure-Smith, N, Talajic, M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996;58:99–110.Google Scholar
28. Ladwig, KH, Kieser, M, Konig, J, Breilhardt, G, Borggrefe, M. Affective disorders and survival after acute myocardial infarction (results from the post-infarction late potential study). Eur Heart J 1991;12:959–964.Google Scholar
29. Ahem, DK, Gorkin, L, Anderson, JL, et al. Biobehavioral variables and mortality on cardiac arrest in the Cardiac Arrhythmia pilot study (CAPS). Am J Cardiol 1990;66:59–62.Google Scholar
30. Havik, OE, Maeland, JG. Patterns of emotional reactions after a myocardial infarction. J Psychosom Res 1990;34:271–285.Google Scholar
31. Forrester, AW, Lipsey, JR, Teitelbaum, ML, DePaulo, JR, Andrzejeweski, PL. Depression following myocardial infarction. Int J Psychiatry Med 1992;22:33–46.Google Scholar
32. Adams, PB, Lawson, S, Sanigorski, A, Sinclair, AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996;31(Suppl):S157–161.Google Scholar
33. Edwards, R, Peet, M, Shay, J, Horrobin, D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998;48:149–155.Google Scholar
34. Dalack, GW, Roose, SP. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 1990:51 (Suppl.):4–9.Google Scholar
35. Rechlin, T, Weis, M, Spitzer, A, Kaschka, WP. Are affective disorders associated with alterations of heart rate variability? J Affect Disord 1994;32:271–275.Google Scholar
36. Carney, RM, Saunders, RD, Freedland, KE, Stein, P, Rich, MW, Jaffe, AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995;76:562–564.Google Scholar
37. Maes, M. Major depression and activation of the inflammatory system. In: Dantzer, R. (Ed.), Cytokines, stress and depression. New York, Kluwer Academic/Plenum Press, 1999.Google Scholar
38. Zalcman, S, Green-Johnson, JM, Murray, L, et al. Cytokine-specific central monoamine alterations induced by interleukin-1, -2, and -6. Brain Res 1994;643:40–49.Google Scholar
39. Block, ER, Edwards, D. Effect of plasma membrane fluidity on serotonin transport by endothelial cells. Am J Physiol 1987;253:C672–678.Google Scholar
40. Hibbeln, JR. Fish consumption and major depression [letter] [see comments]. Lancet 1998:351:1213.Google Scholar
41. Yokogoshi, H, Kimiko, O, Okitsu, M. Accumulation of brain tryptophan in rats after administering various fats or fatty acids. Biosci Biotech Biochem 1993;57:181–184.Google Scholar
42. Bang, HO, Dyerberg, J, Hjoorne, N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976;200:69–73.Google Scholar
43. Kromhout, D, Bosschieter, EB, de Lezenne Coulander, C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205–1209.Google Scholar
44. Simopoulos, AP. Omega-3 fatty acids in health and disease and in growth and development [see comments]. Am J Clin Nutr 1991;54:438–463.Google Scholar
45. Kang, JX, Leaf, A. Antiarrhythmic effects of polyunsaturated fatty acids. Circulation 1996;94:1774–1780.Google Scholar
46. Siscovick, DS, Raghunathan, T, King, I, et al. Dietary intake of longchain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr 2000;71:208S–212S.Google Scholar
47. Kleiger, RE, Miller, JP, Bigger, JT Jr., Moss, AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256–262.Google Scholar
48. Carney, RM, Freedland, KE, Veith, RC, Jaffe, AS. Can treating depression reduce mortality after an acute myocardial infarction? Psychosom Med 1999;61:666–675.Google Scholar
49. Christensen, JH, Korup, E, Aaroe, J, et al. Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 1997;79:1670–1673.Google Scholar
50. Christensen, JH, Gustenhoff, P, Korup, E, et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double-blind randomised controlled trial. BMJ 1996;312:677–678.Google Scholar
51. Musselman, DL, Tomer, A, Manatunga, AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313–1317.Google Scholar
52. Laghrissi-Thode, F, Wagner, WR, Pollock, BG, Johnson, PC, Finkel, MS. Elevated platelet factor 4 and beta-lhromboglobulin plasma levels in depressed patients with ischemic heart disease. Soc Biol Psychiatry 1997;42:290–295.Google Scholar
53. Kuijpers, PMJC, Honig, A, Hamulyak, K, Maes, M, Wellens, HJJ. Blood platelet functioning in post myocardial infarction patients with a major depression, Dutch Conference of Cardiology, The Netherlands, 2000.Google Scholar
54. Yamada, N, Shimizu, J, Wada, M, Takita, T, Innami, S. Changes in platelet aggregation and lipid metabolism in rats given dietary lipids containing different n-3 polyunsaturated fatly acids. J Nutr Sci Vitaminol Tokyo 1998;44:279–289.Google Scholar
55. Ikeda, I, Yoshida, H, Tomooka, M, et al. Effects of long-term feeding of marine oils with different positional distribution of eicosapentaenoic docosahexaenoic acids on lipid metabolism, eicosanoid production, and platelet aggregation in hypercholesterolemic rats. Lipids 1998;33:897–904.Google Scholar
56. Vericel, E, Calzada, C, Chapuy, P, Lagarde, M. The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis 1999;147:187–192.Google Scholar
57. Malie, E, Kostner, GM. Effects of fish oils on lipid variables and platelet function indices. Prostaglandins Leukotr Essent Fatty Acids 1993;49:645–663.Google Scholar
58. Maes, M, Bosmans, E, De Jongh, R, Kenis, G, Vandoolaeghe, E, Neels, H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997;9:853–858.Google Scholar
59. Maes, M, Vandoolaeghe, E, Neels, H, et al. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 1997;42:349–358.Google Scholar
60. Calabrese, JR, Skwerer, RG, Barna, B, et al. Depression, immuno-competence, and prostaglandins of the E series. Psychiatr Res 1986;17:41–47.Google Scholar
61. Ueda, K, Takahashi, M, Ozawa, K, Kinoshita, M. Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction. Am Heart J 1999;138:908–915.Google Scholar
62. Ridker, PM, Rifai, N, Pfeffer, M, Sacks, F, Lepage, S, Braunwald, E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:2149–2153.Google Scholar
63. Ridker, PM, Rifai, N, Stampfer, MJ, Hennekens, CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767–1772.Google Scholar
64. Connor, TJ, Leonard, BE. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 1998;62:583–606.Google Scholar
65. Sluzewska, A, Rybakowski, J, Bosmans, E. Indicators of immune activation in major depression. Psychiatr Res 1996;64:161–167.Google Scholar
66. Maes, M, Vandoolaeghe, E, Ranjan, R, Bosmans, E, Bergmans, R, Desneyder, R. Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J Affect Disord 1995;36:29–36.Google Scholar
67. Maes, M, Meltzer, HY, Bosmans, E, et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6 receptor, soluble interleukin- 2 and transferrin receptor in major depression. J Affect Disord 1995;34:301–309.Google Scholar
68. Maes, M, Scharpe, S, Meltzer, HY, Cosyns, P. Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression. Biol Psychiatry 1993;34:690–701.Google Scholar
69. Maes, M, Scharpe, S, Van Grootel, L, et al. Higher alfal-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 1992;24:183–192.Google Scholar
70. McLoughlin, IJ, Hodge, JS. Zinc in depressive disorder. Acta Psychiatr Scand 1990;82:451–453.Google Scholar
71. Ter Horst, GJ. Emotions and the heart. Acta Neuropsychiatr 1998;10:44–50.Google Scholar
72. Ter Horst, GJ. TNF-alpha-induced selective endothelial leakage and increased mortality risk in postmyocardial infarction depression (letter). Am J Physiol 1998;275:H1910–1911.Google Scholar
73. Lenze, E, Cross, D, McKeel, D, Neuman, RJ, Sheline, YI. White matter hyperintensities and gray matter lesions in physically healthy depressed subjects. Am J Psychiatry 1999;156:1602–1607.Google Scholar
74. McCann, SM, Lyson, K, Karanth, S, et al. Role of cytokines in the endocrine system. Ann N Y Acad Sci 1994;741:50–63.Google Scholar
75. Cerrito, F, Lazzaro, MP, Gaudio, E, Arminio, P, Aloisi, G. 5HT2-receptors and serotonin release: their role in human platelet aggregation. Life Sci 1993;53:209–215.Google Scholar
76. Meydani, SN, Lichtenstein, AH, Cornwall, S, et al. Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J Clin Invest 1993;92:105–113.Google Scholar
77. Calder, PC. Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Braz J Med Biol Res 1998;31:467–490.Google Scholar
78. Suzuki, E, Shintani, F, Kanba, S, Asai, M, Nakaki, T. Induction of interleukin- 1 beta and interleukin -1 receptor antagonist in RNA by chronic treatment with various psychotropics in widespread area of rat brain. Neurosci Lett 1996;215:201–204.Google Scholar
79. Balogh, S, Fitzpatrick, DF, Hendricks, SE, Paige, SR. Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmacol Bull 1993;29:201–206.Google Scholar
80. Strik, JJMH, Honig, A, Lousberg, R, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression following first myocardial infarction: findings from a double-blind placebo- controlled trial. Psychosom Med in press.Google Scholar
81. Stoll, AL, Severus, WE, Freeman, MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial [see comments]. Arch Gen Psychiatry 1999;56:407–412.Google Scholar
82. Maidment, ID. Are fish oils an effective therapy in mental illness-an analysis of the data [In Process Citation]. Acta Psychiatr Scand 2000;102:3–11.Google Scholar